An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid Arthritis

NCT00383188 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
305
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer